Cristina
Nieto Jimenez
![Foto de Cristina](/img/nophoto.png)
![Foto de Universidad de Salamanca](/img/noimage_org.png)
Universidad de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Salamanca (7)
2019
-
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome
OncoImmunology, Vol. 8, Núm. 10
2017
-
BET inhibitors as novel therapeutic agents in breast cancer
Oncotarget, Vol. 8, Núm. 41, pp. 71285-71291
-
DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer
Oncotarget, Vol. 8, Núm. 38, pp. 62834-62841
-
Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors
Oncotarget, Vol. 8, Núm. 13, pp. 21733-21740
-
Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancer
Molecular Cancer Therapeutics, Vol. 16, Núm. 11, pp. 2552-2562
-
Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors
Oncotarget, Vol. 8, Núm. 12, pp. 19478-19490
2016
-
In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: Role of mitotic kinases
Oncotarget, Vol. 7, Núm. 16, pp. 22865-22872